Literature DB >> 27908590

Disease mapping of zero-excessive mesothelioma data in Flanders.

Thomas Neyens1, Andrew B Lawson2, Russell S Kirby3, Valerie Nuyts4, Kevin Watjou5, Mehreteab Aregay2, Rachel Carroll2, Tim S Nawrot6, Christel Faes5.   

Abstract

PURPOSE: To investigate the distribution of mesothelioma in Flanders using Bayesian disease mapping models that account for both an excess of zeros and overdispersion.
METHODS: The numbers of newly diagnosed mesothelioma cases within all Flemish municipalities between 1999 and 2008 were obtained from the Belgian Cancer Registry. To deal with overdispersion, zero inflation, and geographical association, the hurdle combined model was proposed, which has three components: a Bernoulli zero-inflation mixture component to account for excess zeros, a gamma random effect to adjust for overdispersion, and a normal conditional autoregressive random effect to attribute spatial association. This model was compared with other existing methods in literature.
RESULTS: The results indicate that hurdle models with a random effects term accounting for extra variance in the Bernoulli zero-inflation component fit the data better than hurdle models that do not take overdispersion in the occurrence of zeros into account. Furthermore, traditional models that do not take into account excessive zeros but contain at least one random effects term that models extra variance in the counts have better fits compared to their hurdle counterparts. In other words, the extra variability, due to an excess of zeros, can be accommodated by spatially structured and/or unstructured random effects in a Poisson model such that the hurdle mixture model is not necessary.
CONCLUSIONS: Models taking into account zero inflation do not always provide better fits to data with excessive zeros than less complex models. In this study, a simple conditional autoregressive model identified a cluster in mesothelioma cases near a former asbestos processing plant (Kapelle-op-den-Bos). This observation is likely linked with historical local asbestos exposures. Future research will clarify this.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bayesian analysis; Conditional autoregressive convolution model; Disease mapping; Excess zeros; Mesothelioma

Mesh:

Year:  2016        PMID: 27908590      PMCID: PMC5272833          DOI: 10.1016/j.annepidem.2016.10.006

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  18 in total

Review 1.  Common errors in disease mapping.

Authors:  Ricardo Ocaña-Riola
Journal:  Geospat Health       Date:  2010-05       Impact factor: 1.212

2.  High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites.

Authors:  Mehmet Bayram; Isa Dongel; Nur Dilek Bakan; Hüseyin Yalççn; Ruhiye Cevit; Pascal Dumortier; Benoit Nemery
Journal:  Chest       Date:  2013-01       Impact factor: 9.410

3.  Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032.

Authors:  Alfreda Krupoves; Michel Camus; Louise De Guire
Journal:  Am J Ind Med       Date:  2015-03-09       Impact factor: 2.214

4.  Mesothelioma due to domestic exposure to asbestos.

Authors:  K Browne; T Goffe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-14

5.  Residential proximity to naturally occurring asbestos and mesothelioma risk in California.

Authors:  Xue-lei Pan; Howard W Day; Wei Wang; Laurel A Beckett; Marc B Schenker
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

6.  The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil.

Authors:  Eduardo Algranti; Cézar Akiyoshi Saito; Ana Paula Scalia Carneiro; Bruno Moreira; Elizabete Medina Coeli Mendonça; Marco Antonio Bussacos
Journal:  Cancer Epidemiol       Date:  2015-08-25       Impact factor: 2.984

7.  Update of predictions of mortality from pleural mesothelioma in the Netherlands.

Authors:  O Segura; A Burdorf; C Looman
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

8.  Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy.

Authors:  C Magnani; B Terracini; C Ivaldi; M Botta; A Mancini; A Andrion
Journal:  Occup Environ Med       Date:  1995-06       Impact factor: 4.402

9.  Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos.

Authors:  C Magnani; A Agudo; C A González; A Andrion; A Calleja; E Chellini; P Dalmasso; A Escolar; S Hernandez; C Ivaldi; D Mirabelli; J Ramirez; D Turuguet; M Usel; B Terracini
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

10.  A Bayesian hierarchical model with spatial variable selection: the effect of weather on insurance claims.

Authors:  Ida Scheel; Egil Ferkingstad; Arnoldo Frigessi; Ola Haug; Mikkel Hinnerichsen; Elisabeth Meze-Hausken
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2013-01       Impact factor: 1.864

View more
  4 in total

1.  Zero-inflated multiscale models for aggregated small area health data.

Authors:  Mehreteab Aregay; Andrew B Lawson; Christel Faes; Russell S Kirby; Rachel Carroll; Kevin Watjou
Journal:  Environmetrics       Date:  2017-10-01       Impact factor: 1.900

2.  A Bayesian approach for estimating age-adjusted rates for low-prevalence diseases over space and time.

Authors:  Melissa Jay; Jacob Oleson; Mary Charlton; Ali Arab
Journal:  Stat Med       Date:  2021-03-16       Impact factor: 2.497

3.  Mapping maternal mortality rate via spatial zero-inflated models for count data: A case study of facility-based maternal deaths from Mozambique.

Authors:  Osvaldo Loquiha; Niel Hens; Leonardo Chavane; Marleen Temmerman; Nafissa Osman; Christel Faes; Marc Aerts
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

4.  Asbestos Exposure and the Mesothelioma Incidence in Poland.

Authors:  Małgorzata Krówczyńska; Ewa Wilk
Journal:  Int J Environ Res Public Health       Date:  2018-08-13       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.